RAY-B RaySearch Laboratories AB (publ)

16.68USD169.20 SEK · STO-1.11%Mkt Cap: 561.62M USDP/E: 28.47

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology infor…

Institutional holders10 on file

Key Statistics

Company
Market Cap561.62M USD
Enterprise Value586.05M USD
Revenue (TTM)131.38M USD
Gross Profit122.51M USD
Net Income (TTM)22.46M USD
Revenue/Share3.86 USD
Last Price16.68 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees477
CountrySE
SectorHealthcare
IndustryHealth Information Services
ISINSE0000135485
Valuation
P/E (Trailing)28.47
P/E (Forward)25.50
PEG25.65
EV/EBITDA17.34
EV/Revenue4.46
P/S4.27
P/B7.08
EPS (TTM)0.59 USD
EPS (Forward)0.66 USD
52W Range
15.1019% of range23.51
52W High23.51 USD
52W Low15.10 USD
Profitability
Gross Margin92.42%
Oper. Margin23.24%
EBITDA Margin25.72%
Profit Margin16.95%
ROE23.12%
ROA11.44%
ROIC26.82%
ROCE23.18%
Growth
Revenue Growth18.70%
Earnings Growth-9.10%
Cash Flow & Leverage
Operating CF38.16M USD
CapEx (TTM)22.49M USD
FCF Margin10.57%
FCF Yield2.47%
Net Debt24.43M USD
Net Debt/EBITDA0.72
Net Debt/FCF1.76
Balance Sheet
Debt/Equity0.40
Current Ratio1.32
Quick Ratio1.24
Book Value/Sh2.38 USD
Cash/Share0.47 USD
Dividends
Fwd Div Rate0.39 USD
Trail. Div Rate0.39 USD
Div. Yield2.33%
5Y Avg Yield—
Payout Ratio66.45%
Ex-Div DateMay 8, 2026
Pay Date—
Splits
Last Split3:1
Split DateJun 25, 2008
Analyst Consensus
Rating—
Target (Mean)27.36 USD
Upside (mean)+64.0%
Target Range23.17 USD – 31.56 USD
23.17+64.0% to mean31.56
# Analysts2
Ownership
Shares Out.29.80M
Float27.08M
Insiders10.85%
Institutions59.49%
Technical
SMA 5018.02 (-7.4%)
SMA 20019.02 (-12.3%)
Beta0.82
S&P 52W Chg12.00%
Avg Vol (30d)141.87K
Avg Vol (10d)109.98K
Technical Indicators
RSI (14)39.1
MACD-3.9481
MACD Signal-2.8891
MACD Hist.-1.0590
BB Upper20.34 USD
BB Middle17.97 USD
BB Lower15.60 USD
BB Width26.39%
ATR (14)0.6118 USD
Vol Ratio (20d)0.37x

About RaySearch Laboratories (STO: RAY-B)

›

RaySearch Laboratories (STO: RAY-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 477 employees.

The shares were at 169.20 SEK on 20 November 2026, down 22.9% over 52 weeks. Its 52-week range is 153.10 SEK to 238.40 SEK: the price is 29.0% below the high and 10.5% above the low.

At a market capitalisation of 5.70B SEK, it trades at 28.5 times trailing earnings and 25.5 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 32% for RAY-B. It pays a dividend yielding 2.33% (it pays out 66% of its earnings).

RaySearch Laboratories reports return on equity of 23.1%, an operating margin of 23.2% and revenue up 18.7% year over year.

Its debt exceeds its cash by 247.70M SEK, a debt-to-equity ratio of 0.40. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 2 analysts cover the stock; their mean price target of 277.50 SEK is 64.0% above the current price. The next earnings report is expected on 10 February 2027.